AI eye doctor: new system aims to take guesswork out of injection timing

NCT ID NCT07328776

First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 17 times

Summary

This study tests an AI system called FM-VEGF-CDSS that helps doctors decide the best time for anti-VEGF eye injections in people with wet age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. The AI looks at eye scans and medical records to suggest treatment intervals. The trial will enroll 160 participants and measure how accurate the AI's recommendations are compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai general hospital

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shanghai general hospital, Shanghai Jiao Tong University, Shanghai, 200080

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.